0001493152-23-046580.txt : 20231229 0001493152-23-046580.hdr.sgml : 20231229 20231229161536 ACCESSION NUMBER: 0001493152-23-046580 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231227 FILED AS OF DATE: 20231229 DATE AS OF CHANGE: 20231229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Myers Jeff Lynn CENTRAL INDEX KEY: 0001971112 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38892 FILM NUMBER: 231527852 MAIL ADDRESS: STREET 1: C/O BEYOND AIR, INC. STREET 2: 900 STEWART AVENUE, SUITE 301 CITY: GARDEN CITY STATE: NY ZIP: 11530 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Beyond Air, Inc. CENTRAL INDEX KEY: 0001641631 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 473812456 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 900 STEWART AVENUE STREET 2: SUITE 301 CITY: GARDEN CITY STATE: NY ZIP: 11530 BUSINESS PHONE: 516-665-8200 MAIL ADDRESS: STREET 1: 900 STEWART AVENUE STREET 2: SUITE 301 CITY: GARDEN CITY STATE: NY ZIP: 11530 FORMER COMPANY: FORMER CONFORMED NAME: AIT Therapeutics, Inc. DATE OF NAME CHANGE: 20170117 FORMER COMPANY: FORMER CONFORMED NAME: KokiCare, Inc. DATE OF NAME CHANGE: 20150507 4 1 ownership.xml X0508 4 2023-12-27 0 0001641631 Beyond Air, Inc. XAIR 0001971112 Myers Jeff Lynn C/O BEYOND AIR, INC. 900 STEWART AVENUE, SUITE 301 GARDEN CITY NY 11530 0 1 0 0 Chief Medical Officer 0 Common Stock 2023-12-27 4 S 0 3423 2.214 D 46577 D The sales reported on this Form 4 represent shares of common stock of Beyond Air, Inc. sold by the reporting person to cover tax withholding obligations in connection with the vesting of previously granted restricted stock units. This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.15 to $2.34, inclusive. The reporting person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4. /s/ Adam T. Newman, as attorney-in-fact 2023-12-29